Axon Enterprise Reports Q2 Revenue Growth to $669M, Raises 2025 Guidance, and Faces Risks

Sonoma Pharmaceuticals stock surged 95% after its first US over-the-counter product, a hypochlorous acid-based diaper cream, was launched in 3,600 Walmart stores, Amazon, and select US grocery chains. CEO Amy Trombly said the launch marks an important milestone in the company's retail strategy, aiming to make its Microcyn technology widely accessible for parents seeking safe and effective solutions for diaper rash and other skin irritations. Trading volume surged to 42 million shares, exceeding the three-month daily average of 84,000.

Title: Sonoma Pharmaceuticals Stock Soars After Diaper Cream Launch

Sonoma Pharmaceuticals (NASDAQ: SNOA) saw its stock surge by nearly 95% on Thursday, August 14, following the company's launch of its first U.S. over-the-counter (OTC) product, a hypochlorous acid-based diaper cream. The product, available in 3,600 Walmart (NYSE: WMT) stores, on Amazon (NASDAQ: AMZN), and select U.S. grocery chains, has significantly boosted the company's retail presence.

CEO Amy Trombly expressed excitement about the launch, stating, "We are excited to see our strategy of expanding into the over-the-counter space begin to take hold with our first U.S. product targeted to consumers launched into large-scale retail channels." [2]

The market reaction was immediate, with SNOA stock jumping as much as 95% on the day, building on a modest 1.7% gain from the previous day. Year-to-date, shares are up 13.46%, though they remain down 35.04% over the past 12 months. Trading volume surged to 42 million shares, far exceeding the three-month daily average of about 84,000. [1]

This retail rollout marks an important milestone for Sonoma Pharmaceuticals, which has been focusing on making its patented Microcyn technology widely accessible to consumers seeking safe and effective solutions for diaper rash and other skin irritations. [3]

The company's entry into the OTC consumer market is expected to bolster its presence in the consumer healthcare segment, leveraging its established expertise in therapeutic solutions. [2]

References:
[1] https://ca.finance.yahoo.com/news/sonoma-pharmaceuticals-soars-95-walmart-175546462.html
[2] https://www.gurufocus.com/news/3059623/sonoma-pharmaceuticals-announces-launch-of-diaper-rash-product-in-walmart-and-other-us-chains-snoa-stock-news
[3] https://finance.yahoo.com/news/sonoma-pharmaceuticals-announces-launch-diaper-200100151.html